BSE filing, NSE: BAJAJFINSV. Summary written from the filing by ALFA Finder's alert engine.
Bajaj Finserv Ltd: key numbers
- Share price
- ₹1,652.40
- Market cap
- ₹2,64,475 Cr
- Revenue (annual)
- ₹1,50,504 Cr
- Net profit (annual)
- ₹9,801 Cr
- P/E (TTM)
- 26.1×Sector 21.7×
- Promoter holding
- 58.65%-0.06% QoQ
- FII holding
- 8.12%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bajaj Finserv Ltd
All →Bajaj Finserv Management Change
Deepak Reddy appointed CEO Designate of Bajaj General Insurance, a material Bajaj Finserv subsidiary. He assumes MD & CEO role effective April 2027, subject to IRDAI approval.
Bajaj Finserv Merger & Restructuring Worth ₹1 Cr
Bajaj Finserv Limited incorporated a wholly owned subsidiary, Bajaj Reinsurance Limited, for reinsurance business. The investment for this subscription amounts to Rs. 1 Crore.
- Value
- ₹1.00 Cr
Bajaj Finserv Business Update
Bajaj Finserv released monthly premium and new business performance figures for its unlisted insurance subsidiaries, Bajaj General and Bajaj Life, for September 2026.
Bajaj Finserv Board Meeting Date
Bajaj Finserv Ltd scheduled a board meeting for November 3, 2026, to consider and approve its unaudited standalone and consolidated financial results.
Bajaj Finserv Acquisition Worth ₹5,800 Cr
Bajaj Finserv will subscribe to convertible warrants of its subsidiary, Bajaj Finance Ltd, for a total cash consideration of Rs. 5,800 Crore.
- Value
- ₹5,800 Cr
- From
- Bajaj Finance Limited
Bajaj Finserv Management Change
Bajaj Finserv announced the superannuation of Shri Ramaswamy P. Subramaniam, President - Private Equity Investments & Group Strategy Head, effective 30 September 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.